The Wnt connection to tumorigenesis

International Journal of Developmental Biology

Volumn 48, Issue 5-6, 2004, Pages 477-487

  Behrens, Jürgen ^a   Lustig, Barbara ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b KLINIKUM NÜRNBERG   (Germany)

Author keywords

catenin; APC; Mutation; Tumor; Wnt

Indexed keywords

ADENOSINE TRIPHOSPHATASE; APC PROTEIN; AXIN; BETA CATENIN; CALCIUM ION; CASEIN KINASE I; CELL ADHESION MOLECULE; GLYCOPROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HELICASE; KINESIN; MATRILYSIN; MESSENGER RNA; PLAKOGLOBIN; RAC PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; VASCULOTROPIN; WNT PROTEIN;

APOPTOSIS; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CANCER RESEARCH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL MOTILITY; CELL NUCLEUS; CELL TRANSFORMATION; COLON ADENOMA; COLON POLYPOSIS; COLON TUMOR; COLORECTAL CANCER; CYTOPLASM; DESMOID TUMOR; ENDOMETRIUM CARCINOMA; GENE MUTATION; HOMEOSTASIS; HUMAN; MEDULLOBLASTOMA; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTO ONCOGENE; REVIEW; THYROID CARCINOMA; WNT GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BETA CATENIN; CELL MEMBRANE; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS;

EID: 5444265502     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.041815jb     Document Type: Review

References (150)

1. AMIT, S., HATZUBAI, A., BIRMAN, Y., ANDERSEN, J.S., BEN-SHUSHAN, E., MANN, M., BEN-NERIAH, Y. and ALKALAY, I. (2002). Axin-mediated CK1 phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 16: 1066-1076.
2. AOKI, M., HECHT, A., KRUSE, U., KEMLER, R. and VOGT, P.K. (1999). Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc Natl Acad Sci USA 96: 139-144.
3. BAEZA, N., MASUOKA, J., KLEIHUES, P. and OHGAKI, H. (2003). AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22: 632-636.
4. BARKER, N., HURLSTONE, A., MUSISI, H., MILES, A., BIENZ, M. and CLEVERS, H. (2001). The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J 20: 4935-4943.
5. BARTH, A.I., STEWART, D.B. and NELSON, W.J. (1999). T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin. Proc Natl Acad Sci USA 96: 4947-4952.
6. BATLLE, E., HENDERSON, J.T., BEGHTEL, H., VAN DEN BORN, M.M., SANCHO, E., HULS, G., MEELDIJK, J., ROBERTSON, J., VAN DE WETERING, M., PAWSON, T. and CLEVERS, H. (2002). Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111: 251-263.
7. BAUER, A., CHAUVET, S., HUBER, O., USSEGLIO, F., ROTHBACHER, U., ARAGNOL, D., KEMLER, R. and PRADEL, J. (2000). Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. EMBO J 19: 6121-6130.
8. BEHRENS, J. (1999). Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 18: 15-30.
9. BEHRENS, J., JERCHOW, B.A., WURTELE, M., GRIMM, J., ASBRAND, C., WIRTZ, R., KUHL, M., WEDLICH, D. and BIRCHMEIER, W. (1998). Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599.
10. BEHRENS, J., VON KRIES, J.P., KUHL, M., BRUHN, L., WEDLICH, D., GROSSCHEDL, R. and BIRCHMEIER, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642.
11. BHANOT, P., BRINK, M., SAMOS, C.H., HSIEH, J.C., WANG, Y., MACKE, J.P., ANDREW, D., NATHANS, J. and NUSSE, R. (1996). A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382: 225-230.
12. BOON, E.M., VAN DER NEUT, R., VAN DE WETERING, M., CLEVERS, H. and PALS, S.T. (2002). Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 62: 5126-5128.
13. BRABLETZ, T., JUNG, A., DAG, S., HLUBEK, F. and KIRCHNER, T. (1999). beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038.
14. BRABLETZ, T., JUNG, A. and KIRCHNER, T. (2002). Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch 441: 1-11.
15. CADIGAN, K.M. and NUSSE, R. (1997). Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305.
16. CAPELLUTO, D.G., KUTATELADZE, T.G., HABAS, R., FINKIELSTEIN, C.V., HE, X. and OVERDUIN, M. (2002). The DIX domain targets dishevelled to actin stress fibres and vesicular membranes. Nature 419: 726-729.
17. CHEN, S., GUTTRIDGE, D.C., YOU, Z., ZHANG, Z., FRIBLEY, A., MAYO, M.W., KITAJEWSKI, J. and WANG, C.Y. (2001). Wnt-1 signaling inhibits apoptosis by activating beta-catenin/Tcell factor-mediated transcription. J Cell Biol 152: 87-96.
18. CHEON, S.S., CHEAH, A.Y., TURLEY, S., NADESAN, P., POON, R., CLEVERS, H. and ALMAN, B.A. (2002). beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 99: 6973-6978.
19. CHESIRE, D.R., EWING, C.M., SAUVAGEOT, J., BOVA, G.S. and ISAACS, W.B. (2000). Detection and analysis of beta-catenin mutations in prostate cancer. Prostate 45: 323-334.
20. CHEYETTE, B.N., WAXMAN, J.S., MILLER, J.R., TAKEMARU, K., SHELDAHL, L.C., KHLEBTSOVA, N., FOX, E.P., EARNEST, T. and MOON, R.T. (2002). Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell 2: 449-461.
21. CHRISTOFORI, G. (2003). Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 22: 2318-2323.
22. CIANI, L., KRYLOVA, O., SMALLEY, M.J., DALE, T.C. and SALINAS, P.C. (2004). A divergent canonical WNT-signaling pathway regulates microtubule dynamics: Dishevelled signals locally to stabilize microtubules. J Cell Biol 164: 243-253.
23. CLEMENTS, W.M., WANG, J., SARNAIK, A., KIM, O.J., MACDONALD, J., FENOGLIO-PREISER, C., GRODEN, J. and LOWY, A.M. (2002). beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62: 3503-3506.
24. CRAWFORD, H.C., FINGLETON, B.M., RUDOLPH-OWEN, L.A., GOSS, K.J., RUBINFELD, B., POLAKIS, P. and MATRISIAN, L.M. (1999). The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891.
25. DAHMEN, R.P., KOCH, A., DENKHAUS, D., TONN, J.C., SORENSEN, N., BERTHOLD, F., BEHRENS, J., BIRCHMEIER, W., WIESTLER, O.D. and PIETSCH, T. (2001). Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61: 7039-7043.
26. DE LA COSTE, A., ROMAGNOLO, B., BILLUART, P., RENARD, C.A., BUENDIA, M.A., SOUBRANE, O., FABRE, M., CHELLY, J., BELDJORD, C., KAHN, A. and PERRET, C. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851.
27. DOMINGO, E., ESPIN, E., ARMENGOL, M., OLIVEIRA, C., PINTO, M., DUVAL, A., BRENNETOT, C., SERUCA, R., HAMELIN, R., YAMAMOTO, H. and SCHWARTZ, S., JR. (2004). Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 39: 138-142.
28. ESTELLER, M., SPARKS, A., TOYOTA, M., SANCHEZ-CESPEDES, M., CAPELLA, G., PEINADO, M. A., GONZALEZ, S., TARAFA, G., SIDRANSKY, D., MELTZER, S.J., BAYLIN, S.B. and HERMAN, J.G. (2000). Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60: 4366-4371.
29. FENG, Y., LEE, N. and FEARON, E.R. (2003). TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res 63: 8726-8734.
30. FODDE, R., KUIPERS, J., ROSENBERG, C., SMITS, R., KIELMAN, M., GASPAR, C., VAN ES, J.H., BREUKEL, C., WIEGANT, J., GILES, R.H. and CLEVERS, H. (2001). Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3: 433-438.
31. GAMALLO, C., PALACIOS, J., MORENO, G., CALVO DE MORA, J., SUAREZ, A. and ARMAS, A. (1999). beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 155; 527-536.
32. GARCIA-ROSTAN, G., CAMP, R.L., HERRERO, A., CARCANGIU, M.L., RIMM, D.L. and TALLINI, G. (2001). Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158: 987-996.
33. GARCIA-ROSTAN, G., TALLINI, G., HERRERO, A., D'AQUILA, T.G., CARCANGIU, M.L. and RIMM, D.L. (1999). Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59: 1811-1815.
34. GERSTEIN, A.V., ALMEIDA, T.A., ZHAO, G., CHESS, E., SHIH IE, M., BUHLER, K., PIENTA, K., RUBIN, M.A., VESSELLA, R. and PAPADOPOULOS, N. (2002). APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34: 9-16.
35. GILES, R.H., VAN ES, J.H. and CLEVERS, H. (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24.
36. GLOY, J., HIKASA, H. and SOKOL, S.Y. (2002). Frodo interacts with Dishevelled to transduce Wnt signals. Nat Cell Biol. 4: 351-357.
37. GOUNARI, F., SIGNORETTI, S., BRONSON, R., KLEIN, L., SELLERS, W.R., KUM, J., SIERMANN, A., TAKETO, M.M., VON BOEHMER, H. and KHAZAIE, K. (2002). Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene 21: 4099-4107.
38. GROVES, C., LAMLUM, H., CRABTREE, M., WILLIAMSON, J., TAYLOR, C., BASS, S., CUTHBERT-HEAVENS, D., HODGSON, S., PHILLIPS, R. and TOMLINSON, I. (2002). Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160: 2055-2061.
39. HABAS, R., KATO, Y. and HE, X. (2001). Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 107: 843-854.
40. HART, M.J., DE LOS SANTOS, R., ALBERT, I.N., RUBINFELD, B. and POLAKIS, P. (1998). Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573-581.
41. HAYDON, R.C., DEYRUP, A., ISHIKAWA, A., HECK, R., JIANG, W., ZHOU, L., FENG, T., KING, D., CHENG, H., BREYER, B., PEABODY, T., SIMON, M.A., MONTAG, A.G. and HE, T.C. (2002). Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer 102: 338-342.
42. HE, T.C., SPARKS, A.B., RAGO, C., HERMEKING, H., ZAWEL, L., DA COSTA, L.T., MORIN, P.J., VOGELSTEIN, B. and KINZLER, K.W. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
43. HECHT, A., VLEMINCKX, K., STEMMLER, M.P., VAN ROY, F. and KEMLER, R. (2000). The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J 19: 1839-1850.
44. HEISENBERG, C.P. (2002). Wnt signalling: refocusing on Strabismus. Curr Biol 12: R657-659.
45. HILTUNEN, M.O., ALHONEN, L., KOISTINAHO, J., MYOHANEN, S., PAAKKONEN, M., MARIN, S., KOSMA, V.M. and JANNE, J. (1997). Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 70: 644-648.
46. HLUBEK, F., JUNG, A., KOTZOR, N., KIRCHNER, T. and BRABLETZ, T. (2001). Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res 61: 8089-8093.
47. HSU, S.C., GALCERAN, J. and GROSSCHEDL, R. (1998). Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol 18: 4807-4818.
48. HUANG, H., MAHLER-ARAUJO, B.M., SANKILA, A., CHIMELLI, L, YONEKAWA, Y., KLEIHUES, P. and OHGAKI, H. (2000). APC mutations in sporadic medulloblastomas. Am J Pathol 156: 433-437.
49. HUBER, A.H. and WEIS, W.I. (2001). The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 105: 391-402.
50. HUBER, O., KORN, R., MCLAUGHLIN, J., OHSUGI, M., HERRMANN, B.G. and KEMLER, R. (1996). Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3-10.
51. HULSKEN, J., BIRCHMEIER, W. and BEHRENS, J. (1994). E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127: 2061-2069.
52. IKEDA, S., KISHIDA, S., YAMAMOTO, H., MURAI, H., KOYAMA, S. and KIKUCHI, A. (1998). Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17: 1371-1384.
53. INOMATA, M., OCHIAI, A., AKIMOTO, S., KITANO, S. and HIROHASHI, S. (1996). Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 56: 2213-2217.
54. JHO, E.H., ZHANG, T., DOMON, C., JOO, C.K., FREUND, J.N. and COSTANTINI, F. (2002). Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183.
55. JIMBO, T., KAWASAKI, Y., KOYAMA, R., SATO, R., TAKADA, S., HARAGUCHI, K. and AKIYAMA, T. (2002). Identification of a link between the tumour suppressor APC and the kinesin superfamily. Nat Cell Biol 4: 323-327.
56. KAPLAN, D.D., MEIGS, T.E., KELLY, P. and CASEY, P.J. (2004). Identification of a role for beta -catenin in the establishment of a bipolar mitotic spindle. J Biol Chem.
57. KAPLAN, K.B., BURDS, A.A., SWEDLOW, J.R., BEKIR, S.S., SORGER, P.K. and NATHKE, I.S. (2001). A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol 3: 429-432.
58. KAWASAKI, Y., SATO, R., AKIYAMA, T., SENDA, T., ISHIDATE, T., KOYAMA, R., MORISHITA, T., IWAYAMA, Y. and HIGUCHI, O. (2003). Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat Cell Biol 5:211-215.
59. KAWASAKI, Y., SENDA, T., ISHIDATE, T., KOYAMA, R., MORISHITA, T., IWAYAMA, Y., HIGUCHI, O. and AKIYAMA, T. (2000). Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289: 1194-1197.
60. KIM, P.J., PLESCIA, J., CLEVERS, H., FEARON, E.R. and ALTIERI, D.C. (2003). Survivin and molecular pathogenesis of colorectal cancer. Lancet 362: 205-209.
61. KINZLER, K.W. and VOGELSTEIN, B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.
62. KISHIDA, S., YAMAMOTO, H., IKEDA, S., KISHIDA, M., SAKAMOTO, I., KOYAMA, S. and KIKUCHI, A. (1998). Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273: 10823-10826.
63. KITAEVA, M.N., GROGAN, L., WILLIAMS, J.P., DIMOND, E., NAKAHARA, K., HAUSNER, P., DENOBILE, J.W., SOBALLE, P.W. and KIRSCH, I.R. (1997). Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 57: 4478-4481.
64. KITAGAWA, M., HATAKEYAMA, S., SHIRANE, M., MATSUMOTO, M., ISHIDA, N., HATTORI, K., NAKAMICHI, I., KIKUCHI, A. and NAKAYAMA, K. (1999). An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 18: 2401-2410.
65. KOCH, A., DENKHAUS, D, ALBRECHT, S., LEUSCHNER, I., VON SCHWEINITZ, D. and PIETSCH, T. (1999). Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59: 269-273.
66. KOCH, A., WAHA, A., TONN, J.C., SORENSEN, N., BERTHOLD, F., WOLTER, M., REIFENBERGER, J., HARTMANN, W., FRIEDL, W., REIFENBERGER, G., WIESTLER, O.D. and PIETSCH, T. (2001). Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93: 445-449.
67. KOESTERS, R., RIDDER, R., KOPP-SCHNEIDER, A., BETTS, D., ADAMS, V., NIGGLI, F., BRINER, J. and VON KNEBEL DOEBERITZ, M. (1999). Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59: 3880-3882.
68. KOLLIGS, F.T., HU, G., DANG, C.V. and FEARON, E.R. (1999). Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol 19: 5696-5706.
69. KORINEK, V., BARKER, N., MORIN, P.J., VAN WICHEN, D., DE WEGER, R., KINZLER, K.W., VOGELSTEIN, B. and CLEVERS, H. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
70. KRAMPS, T., PETER, O., BRUNNER, E., NELLEN, D., FROESCH, B., CHATTERJEE, S., MURONE, M., ZULLIG, S. and BASLER, K. (2002). Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109: 47-60.
71. KUHL, M. (2004). The WNT/Calcium pathway: biochemical mediators, tools and future requirements. Front Biosci 9: 967-974.
72. KUSAFUKA, T., MIAO, J., KURODA, S., UDATSU, Y. and YONEDA, A. (2002). Codon 45 of the beta-catenin gene, a specific mutational target site of Wilms' tumor. Int J Mol Med 10: 395-399.
73. LEE, J.H., ABRAHAM, S.C., KIM, H.S., NAM, J.H., CHOI, C., LEE, M.C., PARK, C.S., JUHNG, S.W., RASHID, A., HAMILTON, S.R. and WU, T.T. (2002). Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161: 611-618.
74. LEPOURCELET, M., CHEN, Y.N., FRANCE, D.S., WANG, H., CREWS, P., PETERSEN, F., BRUSEO, C., WOOD, A.W. and SHIVDASANI, R.A. (2004). Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5: 91-102.
75. LEUNG, J.Y., KOLLIGS, F.T., WU, R., ZHAI, Y., KUICK, R., HANASH, S., CHO, K.R. and FEARON, E.R. (2002). Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 277: 21657-21665.
76. LIU, C., LI, Y., SEMENOV, M., HAN, C., BAEG, G.H., TAN, Y., ZHANG, Z., LIN, X. and HE, X. (2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847.
77. LIU, W., DONG, X., MAI, M., SEELAN, R.S., TANIGUCHI, K., KRISHNADATH, K.K., HALLING, K.C., CUNNINGHAM, J.M., BOARDMAN, LA., QIAN, C., CHRISTENSEN, E., SCHMIDT, S.S., ROCHE, P.C., SMITH, D.I. and THIBODEAU, S.N. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26: 146-147.
78. LUSTIG, B. and BEHRENS, J. (2003). The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129: 199-221.
79. LUSTIG, B., JERCHOW, B., SACHS, M., WEILER, S., PIETSCH, T., KARSTEN, U., VAN DE WETERING, M., CLEVERS, H., SCHLAG, P.M., BIRCHMEIER, W. and BEHRENS, J. (2002). Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184-1193.
80. MAITI, S., ALAM, R., AMOS, C.I. and HUFF, V. (2000). Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60: 6288-6292.
81. MAO, B., WU, W., DAVIDSON, G., MARHOLD, J., LI, M., MECHLER, B.M., DELIUS, H., HOPPE, D., STANNEK, P., WALTER, C., GLINKA, A. and NIEHRS, C. (2002). Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417: 664-667.
82. MAO, B., WU, W., LI, Y., HOPPE, D., STANNEK, P., GLINKA, A. and NIEHRS, C. (2001a). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321-325.
83. MAO, J., WANG, J., LIU, B., PAN, W., FARR, G.H., 3RD, FLYNN, C., YUAN, H., TAKADA, S., KIMELMAN, D., LI, L. and WU, D. (2001b). Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809.
84. MARCHENKO, G.N., MARCHENKO, N.D., LENG, J. and STRONGIN, A.Y. (2002). Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J 363: 253-262.
85. MILLER, J.R. (2002). The Wnts. Genome Biol 3: REVIEWS3001.
86. MIRABELLI-PRIMDAHL, L, GRYFE, R., KIM, H., MILLAR, A., LUCERI, C., DALE, D., HOLOWATY, E., BAPAT, B., GALLINGER, S. and REDSTON, M. (1999). Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59: 3346-3351.
87. MIYAKI, M., IIJIMA, T., KIMURA, J., YASUNO, M., MORI, T., HAYASHI, Y., KOIKE, M., SHITARA, N., IWAMA, T. and KUROKI, T. (1999). Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59: 4506-4509.
88. MOGENSEN, M.M., TUCKER, J.B., MACKIE, J.B., PRESCOTT, A.R. and NATHKE, I. S. (2002). The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 157: 1041-1048.
89. MOLENAAR, M., VAN DE WETERING, M., OOSTERWEGEL, M., PETERSON-MADURO, J., GODSAVE, S., KORINEK, V., ROOSE, J., DESTREE, O. and CLEVERS, H. (1996). XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
90. MORENO-BUENO, G., HARDISSON, D., SANCHEZ, C., SARRIO, D., CASSIA, R., GARCIA-ROSTAN, G., PRAT, J., GUO, M., HERMAN, J.G., MATIAS-GUIU, X., ESTELLER, M. and PALACIOS, J. (2002). Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21: 7981-7990.
91. MORIN, P.J., SPARKS, A.B., KORINEK, V., BARKER, N., CLEVERS, H., VOGELSTEIN, B. and KINZLER, K.W. (1997). Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790.
92. MULHOLLAND, D.J., CHENG, H., REID, K., RENNIE, P.S. and NELSON, C.C. (2002). The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 277:17933-17943.
93. NATHKE, I.S., ADAMS, C.L., POLAKIS, P., SELLIN, J.H. and NELSON, W.J. (1996). The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134: 165-179.
94. OLMEDA, D., CASTEL, S., VILARO, S. and CANO, A. (2003). Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Mol Biol Cell 14: 2844-2860.
95. ORFORD, K., ORFORD, C.C. and BYERS, S.W. (1999). Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146: 855-868.
96. OUGOLKOV, A.V., YAMASHITA, K., MAI, M. and MINAMOTO, T. (2002). Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 122: 60-71.
97. PARK, W.S., OH, R.R., PARK, J.Y., KIM, P.J., SHIN, M.S., LEE, J.H., KIM, H.S., LEE, S.H., KIM, S.Y., PARK, Y.G., AN, W.G., JANG, J.J., YOO, N.J. and LEE, J.Y. (2001). Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193: 483-490.
98. PARK, W.S., OH, R.R., PARK, J.Y., LEE, S.H., SHIN, M.S., KIM, Y.S., KIM, S.Y., LEE, H.K., KIM, P.J., OH, S.T., YOO, N.J. and LEE, J.Y. (1999). Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59: 4257-4260.
99. PEIFER, M., BERG, S. and REYNOLDS, A.B. (1994). A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 76: 789-791.
100. POLAKIS, P. (2000). Wnt signaling and cancer. Genes Dev 14: 1837-1851.
101. RIJSEWIJK, F., SCHUERMANN, M., WAGENAAR, E., PARREN, P., WEIGEL, D. and NUSSE, R. (1987a). The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50: 649-657.
102. RIJSEWIJK, F., VAN DEEMTER, L, WAGENAAR, E., SONNENBERG, A. and NUSSE, R. (1987b). Transfection of the int-1 mammary oncogene in cuboidal RAC mammary cell line results in morphological transformation and tumorigenicity. EMBO J 6: 127-131.
103. RIMM, D.L., CACA, K., HU, G., HARRISON, F.B. and FEARON, E.R. (1999). Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154: 325-329.
104. ROOSE, J., HULS, G., VAN BEEST, M., MOERER, P., VAN DER HORN, K., GOLDSCHMEDING, R., LOGTENBERG, T. and CLEVERS, H. (1999). Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285: 1923-1926.
105. ROOSE, J., MOLENAAR, M., PETERSON, J., HURENKAMP, J., BRANTJES, H., MOERER, P., VAN DE WETERING, M., DESTREE, O. and CLEVERS, H. (1998). The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395: 608-612.
106. ROSIN-ARBESFELD, R., CLIFFE, A., BRABLETZ, T. and BIENZ, M. (2003). Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J 22: 1101-1113.
107. ROUSSET, R., MACK, J.A., WHARTON, K.A., JR., AXELROD, J.D., CADIGAN, K.M., FISH, M.P., NUSSE, R. and SCOTT, M.P. (2001). Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes Dev 15: 658-671.
108. RUBINFELD, B., ALBERT, I., PORFIRI, E., FIOL, C., MUNEMITSU, S. and POLAKIS, P. (1996). Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272: 1023-1026.
109. RUCKERT, S., HIENDLMEYER, E., BRUECKL, W.M., OSWALD, U., BEYSER, K., DIETMAIER, W., HAYNL, A., KOCH, C., RUSCHOFF, J., BRABLETZ, T., KIRCHNER, T. and JUNG, A. (2002). T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis. Cancer Res 62: 3009-3013.
110. SATOH, S., DAIGO, Y., FURUKAWA, Y., KATO, T., MIWA, N., NISHIWAKI, T., KAWASOE, T., ISHIGURO, H., FUJITA, M., TOKINO, T., SASAKI, Y., IMAOKA, S., MURATA, M., SHIMANO, T., YAMAOKA, Y. and NAKAMURA, Y. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250.
111. SCHWARTZ, D.R., WU, R., KARDIA, S.L., LEVIN, A.M., HUANG, C.C., SHEDDEN, K.A., KUICK, R., MISEK, D.E., HANASH, S.M., TAYLOR, J.M., REED, H., HENDRIX, N., ZHAI, Y., FEARON, E.R. and CHO, K.R. (2003). Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 63: 2913-2922.
112. SCHWARZ-ROMOND, T., ASBRAND, C., BAKKERS, J., KUHL, M., SCHAEFFER, H.J., HUELSKEN, J., BEHRENS, J., HAMMERSCHMIDT, M. and BIRCHMEIER, W. (2002). The ankyrin repeat protein Diversin recruits Casein kinase lepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev 16: 2073-2084.
113. SEELING, J.M., MILLER, J.R., GIL, R., MOON, R.T., WHITE, R. and VIRSHUP, D.M. (1999). Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283: 2089-2091.
114. SEIDENSTICKER, M.J. and BEHRENS, J. (2000). Biochemical interactions in the wnt pathway. Biochim Biophys Acta 1495: 168-182.
115. SHIMIZU, H., JULIUS, M.A., GIARRE, M., ZHENG, Z., BROWN, A.M. and KITAJEWSKI, J. (1997). Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ B: 1349-1358.
116. SHIMOKAWA, T., FURUKAWA, Y., SAKAI, M., LI, M., MIWA, N., LIN, Y.M. and NAKAMURA, Y. (2003). Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res 63: 6116-6120.
117. SHTUTMAN, M., ZHURINSKY, J., SIMCHA, I., ALBANESE, C., D'AMICO, M., PESTELL, R. and BEN-ZE'EV, A. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527.
118. SPARKS, A.B., MORIN, P.J., VOGELSTEIN, B. and KINZLER, K.W. (1998). Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134.
119. SPINK, K.E., POLAKIS, P. and WEIS, W.I. (2000). Structural basis of the Axinadenomatous polyposis coli interaction. EMBO J 19: 2270-2279.
120. STOCKINGER, A., EGER, A., WOLF, J., BEUG, H. and FOISNER, R. (2001). E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 154: 1185-1196.
121. SUN, T.Q., LU, B., FENG, J.J., REINHARD, C., JAN, Y.N., FANTL, W.J. and WILLIAMS, L.T. (2001). PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 3: 628-636.
122. TAGO, K., NAKAMURA, T., NISHITA, M., HYODO, J., NAGAI, S., MURATA, Y., ADACHI, S., OHWADA, S., MORISHITA, Y., SHIBUYA, H. and AKIYAMA, T. (2000). Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 14: 1741-1749.
123. TAKEMARU, K., YAMAGUCHI, S., LEE, Y.S., ZHANG, Y., CARTHEW, R.W. and MOON, R.T. (2003). Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 422: 905-909.
124. TAMAI, K., SEMENOV, M., KATO, Y., SPOKONY, R., LIU, C., KATSUYAMA, Y., HESS, F., SAINT-JEANNET, J.P. and HE, X. (2000). LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530-535.
125. TANIGUCHI, K., ROBERTS, L.R., ADERCA, I.N., DONG, X., QIAN, C., MURPHY, L.M., NAGORNEY, D.M., BURGART, L.J., ROCHE, P.C., SMITH, D.I., ROSS, J.A. and LIU, W. (2002). Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogens 21: 4863-4871.
126. TETSU, O. and MCCORMICK, F. (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
127. THOMPSON, B., TOWNSLEY, F., ROSIN-ARBESFELD, R., MUSISI, H. and BIENZ, M. (2002). A new nuclear component of the Wnt signalling pathway. Nat Cell Biol 4: 367-373.
128. TRUICA, C.I., BYERS, S. and GELMANN, E.P. (2000). Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60: 4709-4713.
129. VAN DE WETERING, M., CAVALLO, R., DOOIJES, D., VAN BEEST, M., VAN ES, J., LOUREIRO, J., YPMA, A., HURSH, D., JONES, T., BEJSOVEC, A., PEIFER, M., MORTIN, M. and CLEVERS, H. (1997). Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789-799.
130. VAN DE WETERING, M., OVING, I., MUNCAN, V., PON FONG, M.T., BRANTJES, H., VAN LEENEN, D., HOLSTEGE, F.C., BRUMMELKAMP, T.R., AGAMI, R. and CLEVERS, H. (2003). Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615.
131. VAN DE WETERING, M., SANCHO, E., VERWEIJ, C., DE LAU, W., OVING, I., HURLSTONE, A., VAN DER HORN, K., BATLLE, E., COUDREUSE, D., HARAMIS, A.P., TJON-PON-FONG, M., MOERER, P., VAN DEN BORN, M., SOETE, G., PALS, S., EILERS, M., MEDEMA, R. and CLEVERS, H. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
132. VEEMAN, M.T., AXELROD, J.D. and MOON, R.T. (2003). A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5: 367-377.
133. VOELLER, H.J., TRUICA, C.I. and GELMANN, E.P. (1998). Beta-catenin mutations in human prostate cancer. Cancer Res 58: 2520-2523.
134. VON KRIES, J.P., WINBECK, G., ASBRAND, C., SCHWARZ-ROMOND, T., SOCHNIKOVA, N., DELL'ORO, A., BEHRENS, J. and BIRCHMEIER, W. (2000). Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol 7: 800-807.
135. WAKEFIELD, J.G., STEPHENS, D.J. and TAVARE, J.M. (2003). A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 116: 637-646.
136. WEHRLI, M., DOUGAN, S.T., CALDWELL, K., O'KEEFE, L., SCHWARTZ, S., VAIZEL-OHAYON, D., SCHEJTER, E., TOMLINSON, A. and DINARDO, S. (2000). arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527-530.
137. WHARTON, K.A., JR. (2003). Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol 253: 1-17.
138. WIDLUND, H.R., HORSTMANN, M.A., PRICE, E.R., CUI, J., LESSNICK, S.L., WU, M., HE, X. and FISHER, D.E. (2002). Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J Cell Biol 158: 1079-1087.
139. WIELENGA, V.J., SMITS, R., KORINEK, V., SMIT, L, KIELMAN, M., FODDE, R., CLEVERS, H. and PALS, S.T. (1999). Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154: 515-523.
140. WINSTON, J.T., STRACK, P., BEER-ROMERO, P., CHU, C.Y., ELLEDGE, S.J. and HARPER, J.W. (1999). The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13: 270-283.
141. WU, R., ZHAI, Y., FEARON, E.R. and CHO, K.R. (2001). Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61: 8247-8255.
142. YAMAMOTO, H., KISHIDA, S., KISHIDA, M., IKEDA, S., TAKADA, S. and KIKUCHI, A. (1999). Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274: 10681-10684.
143. YANG, F., LI, X., SHARMA, M., SASAKI, C.Y., LONGO, D.L., LIM, B. and SUN, Z. (2002). Linking beta-catenin to androgen-signaling pathway. J Biol Chem 277: 11336-11344.
144. YOST, C., FARR, G.H., 3RD, PIERCE, S.B., FERKEY, D.M., CHEN, M.M. and KIMELMAN, D. (1998). GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93: 1031-1041.
145. YOUNG, C.S., KITAMURA, M., HARDY, S. and KITAJEWSKI, J. (1998). Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol 18: 2474-2485.
146. ZENG, L., FAGOTTO, F., ZHANG, T., HSU, W., VASICEK, T.J., PERRY, W.L., 3RD, LEE, J.J., TILGHMAN, S.M., GUMBINER, B.M. and COSTANTINI, F. (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192.
147. ZHANG, T., OTEVREL, T., GAO, Z., EHRLICH, S.M., FIELDS, J.Z. and BOMAN, B.M. (2001a). Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61: 8664-8667.
148. ZHANG, X., GASPARD, J.P. and CHUNG, D.C. (2001b). Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61: 6050-6054.
149. ZUMBRUNN, J., KINOSHITA, K., HYMAN, A.A. and NATHKE, I.S. (2001). Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation. Curr Biol 11: 44-49.
150. ZURAWEL, R.H., CHIAPPA, S.A., ALLEN, C. and RAFFEL, C. (1998). Sporadic